DK1796480T3 - Fermenterede mælkeproteiner, der omfatter receptor-ligand, og anvendelser deraf - Google Patents

Fermenterede mælkeproteiner, der omfatter receptor-ligand, og anvendelser deraf

Info

Publication number
DK1796480T3
DK1796480T3 DK05784554.7T DK05784554T DK1796480T3 DK 1796480 T3 DK1796480 T3 DK 1796480T3 DK 05784554 T DK05784554 T DK 05784554T DK 1796480 T3 DK1796480 T3 DK 1796480T3
Authority
DK
Denmark
Prior art keywords
receptor ligand
fermented milk
milk proteins
mammal
relief
Prior art date
Application number
DK05784554.7T
Other languages
English (en)
Inventor
Benedicte Flambard
Original Assignee
Chr Hansen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chr Hansen As filed Critical Chr Hansen As
Application granted granted Critical
Publication of DK1796480T3 publication Critical patent/DK1796480T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Medical Informatics (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Endocrinology (AREA)
DK05784554.7T 2004-09-03 2005-09-05 Fermenterede mælkeproteiner, der omfatter receptor-ligand, og anvendelser deraf DK1796480T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401339 2004-09-03
PCT/EP2005/054363 WO2006024673A1 (en) 2004-09-03 2005-09-05 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof

Publications (1)

Publication Number Publication Date
DK1796480T3 true DK1796480T3 (da) 2012-02-13

Family

ID=35344722

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05784554.7T DK1796480T3 (da) 2004-09-03 2005-09-05 Fermenterede mælkeproteiner, der omfatter receptor-ligand, og anvendelser deraf

Country Status (12)

Country Link
US (2) US7883697B1 (da)
EP (1) EP1796480B1 (da)
JP (1) JP2008511593A (da)
CN (1) CN101035433B (da)
AT (1) ATE532416T1 (da)
AU (1) AU2005279163B2 (da)
BR (1) BRPI0514903A (da)
CA (1) CA2577613C (da)
DK (1) DK1796480T3 (da)
NZ (1) NZ554278A (da)
RU (1) RU2403051C2 (da)
WO (1) WO2006024673A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1796480T3 (da) * 2004-09-03 2012-02-13 Chr Hansen As Fermenterede mælkeproteiner, der omfatter receptor-ligand, og anvendelser deraf
JP2009046456A (ja) * 2007-08-23 2009-03-05 Kikkoman Corp 生殖行動の誘発用組成物
ITTO20110631A1 (it) * 2010-07-15 2012-01-16 Oleg Iliich Epshtein Composizione farmaceutica di combinazione e metodi per trattare patologie del sistema genitourinario
FR2962656A1 (fr) 2010-07-15 2012-01-20 Oleg Iliich Epshtein Procede pour augmenter l'effet d'une forme activee-potentialisee d'un anticorps
ITPI20110033A1 (it) * 2011-04-01 2012-10-02 Funcional Food Res S R L Preparazione alimentare funzionale ad uso maschile.
FI126711B (fi) * 2011-10-12 2017-04-13 Gut Guide Oy Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
WO2016182053A1 (ja) 2015-05-13 2016-11-17 アサヒカルピスウェルネス株式会社 運動時の心拍数上昇抑制方法及び心拍数上昇抑制組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436264A (en) * 1993-08-19 1995-07-25 Syntex (U.S.A.) Inc. N-aryloxyalkyl tryptamine α1 -adrenergic receptor antagonists
US5637617A (en) * 1994-04-01 1997-06-10 The Regents Of The University Of California Methods for use of GABAa receptor GABAergic compounds
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
WO1998043498A1 (fr) * 1997-04-01 1998-10-08 Nichimo Co., Ltd. Produit comprenant un ingredient favorable a la sante et son procede de production
US5854029A (en) 1996-08-02 1998-12-29 Calpis Co., Ltd. Method for preparing antihypertensive agent
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤
JP3028411B2 (ja) 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
FI113741B (fi) 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
CA2415688A1 (en) 2000-05-08 2001-11-15 Anand Rao Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
WO2003082019A2 (en) * 2002-04-03 2003-10-09 Chr. Hansen A/S Peptides with anti-hypertensive properties
US20040077624A1 (en) * 2002-05-23 2004-04-22 Pfizer Inc. Novel combination
CN100451127C (zh) * 2002-08-09 2009-01-14 科·汉森有限公司 制备具有抗高血压特性的肽的方法
DK1796480T3 (da) * 2004-09-03 2012-02-13 Chr Hansen As Fermenterede mælkeproteiner, der omfatter receptor-ligand, og anvendelser deraf

Also Published As

Publication number Publication date
RU2403051C2 (ru) 2010-11-10
CA2577613A1 (en) 2006-03-09
EP1796480A1 (en) 2007-06-20
WO2006024673A1 (en) 2006-03-09
JP2008511593A (ja) 2008-04-17
CA2577613C (en) 2015-12-15
ATE532416T1 (de) 2011-11-15
AU2005279163A1 (en) 2006-03-09
US20110195891A1 (en) 2011-08-11
EP1796480B1 (en) 2011-11-09
BRPI0514903A (pt) 2008-06-24
AU2005279163B2 (en) 2012-02-02
CN101035433A (zh) 2007-09-12
CN101035433B (zh) 2011-09-07
US8367604B2 (en) 2013-02-05
US7883697B1 (en) 2011-02-08
NZ554278A (en) 2009-11-27
RU2007112116A (ru) 2008-10-10

Similar Documents

Publication Publication Date Title
DK1796480T3 (da) Fermenterede mælkeproteiner, der omfatter receptor-ligand, og anvendelser deraf
MY148140A (en) A processed meat product or a fish paste product and method for producing the same
TW200628078A (en) Method for enhancing acrylamide decompsistion
MY146570A (en) Method for production of processed livestock meat food or processed sea food, and enzyme preparation for improvement of processed livestock meat food or processed sea food
CY1109701T1 (el) Συνθεση τροφης για ζωα
NO20051993D0 (no) Framgangsmate og fôr for reduksjon av innholdet av uonskede naeringsstoffer i avlopsvann fra fiskeoppdrettsanlegg
EA200700660A1 (ru) Мясные продукты и способ их получения
GB201116841D0 (en) Methods of ensiling algae, ensiled algae and uses of ensiled algae
WO2008046993A3 (fr) Nouveau produit biologique d'origine marine, son procede d'obtention et ses utilisations
ATE556603T1 (de) Enzymbehandlung zur herstellung eines haferprodukts mit veränderter stärke und miteinem erhöhtem glucose- und beta-glucan-gehalt
MX2015007884A (es) Composicion de alimento para animales y proceso para produccion.
CN105541456A (zh) 一种有助于促进辣椒光合作用提高产量的高效肥料及其制备方法
CN204861110U (zh) 一种野菜加工用斩拌机
CN201683573U (zh) 一种新型碗
RU2541650C1 (ru) Способ приготовления кормовой добавки из каныги для откорма рыб
CN107279589A (zh) 增强鱼类肉质的饲料、饲料制作方法及鱼类饲养方法
Lohmann Production of Cowpeas-A manual for users and trainers (Why, Where, What, When & How)
Sarma ATTRACTING JAPANESE FDI TO NER AND ENHANCING MARKET LINKAGES WITH
Lokesh STUDIES ON THE EFFECT OF PEG PRIMING ON SEED QUALITY AND BIOCHEMICAL CHANGES IN BENDI {Abelmoschus esculentus L.
MX345885B (es) Dispositivo de mezclado de alimentacion y su uso.
CN203015648U (zh) 一种草鱼或脆肉鲩与对虾混合养殖***
ATE375091T1 (de) Zusammensetzung enthaltend ton und polysaccharide als zusatzstoff zur stabilisation von komplett- schweinefutter in flussiger form, ihre verwendung und herstellungsverfahren
RU2004117658A (ru) Способ приготовления корма
RU2016152798A (ru) Пиво безалкогольное
TW200712033A (en) A treatment method for kitchen waste